|
|
||||||||
The Journal of Immunology, Vol 156, Issue 12 4783-4788, Copyright © 1996 by American Association of Immunologists
ARTICLES |
RW Burlingame, MA Volzer, J Harris and TW Du Clos
Department of Veterans Affairs Medical Center, Albuquerque, NM 87108, USA.
The clearance of nucleosome core particles and H1-stripped chromatin from the circulation of mice was examined. Radiolabeled chromatin preparations were injected into mice, and blood samples were obtained over 60 min. The animals were then killed, and the selected organs were collected and radioactivity was measured. The acute phase response (APR) was induced by i.p. injections of casein before some clearance studies. Serum amyloid P component, the major acute phase protein in mice, increased from 27 microg/ml to 339 microg/ml during the acute phase. The rate of chromatin clearance decreased during the acute phase in C57BL/10J mice. At 5 min, 18% +/- 3% of the originally measured radioactivity remained in control animals compared with 49% +/- 2% in acute phase animals (p < 0.001). Co-injection of either serum amyloid P component or C-reactive protein, the major acute phase protein in humans, caused a decrease in the rate of chromatin clearance similar to that observed following the induction of the APR. APR induction also caused a higher percentage of the chromatin to localize in the liver compared with the spleen, with the ratio changing from 10.2 +/- 0.7 to 16.1 +/- 1.9 (p < 0.004). In addition, the APR caused a decrease in the percentage of chromatin localized in the kidney. The lack of radioactivity associated with cells in the circulation indicates that complement is not a major factor in the clearance mechanism of chromatin. These findings suggest that the APR produces major changes in the rate and path of chromatin clearance. These changes may protect against deposition of chromatin in target organs of systemic lupus erythematosus.
This article has been cited by other articles:
![]() |
W. Rodriguez, C. Mold, M. Kataranovski, J. A. Hutt, L. L. Marnell, J. S. Verbeek, and T. W. Du Clos C-Reactive Protein-Mediated Suppression of Nephrotoxic Nephritis: Role of Macrophages, Complement, and Fc{gamma} Receptors J. Immunol., January 1, 2007; 178(1): 530 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim, C. L. Bronson, W. L. Hayton, M. D. Radmacher, D. C. Roopenian, J. M. Robinson, and C. L. Anderson Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G352 - G360. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Pitiphat, M. W. Gillman, K. J. Joshipura, P. L. Williams, C. W. Douglass, and J. W. Rich-Edwards Plasma C-Reactive Protein in Early Pregnancy and Preterm Delivery Am. J. Epidemiol., December 1, 2005; 162(11): 1108 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Holdenrieder, P. Stieber, J. von Pawel, H. Raith, D. Nagel, K. Feldmann, and D. Seidel Circulating Nucleosomes Predict the Response to Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer Clin. Cancer Res., September 15, 2004; 10(18): 5981 - 5987. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Belcher, C. J. Bryant, J. Nguyen, P. R. Bowlin, M. C. Kielbik, J. C. Bischof, R. P. Hebbel, and G. M. Vercellotti Transgenic sickle mice have vascular inflammation Blood, May 15, 2003; 101(10): 3953 - 3959. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shi, C. Xie, D. Kreska, J. A. Richardson, and C. Mohan Genetic Dissection of SLE: SLE1 and FAS Impact Alternate Pathways Leading to Lymphoproliferative Autoimmunity J. Exp. Med., August 5, 2002; 196(3): 281 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mold, B. Rodic-Polic, and T. W. Du Clos2 Protection from Streptococcus pneumoniae Infection by C-Reactive Protein and Natural Antibody Requires Complement But Not Fc{gamma} Receptors J. Immunol., June 15, 2002; 168(12): 6375 - 6381. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. HOLDENRIEDER, P. STIEBER, H. BODENMULLER, M. BUSCH, J. V. PAWEL, A. SCHALHORN, D. NAGEL, and D. SEIDEL Circulating Nucleosomes in Serum Ann. N.Y. Acad. Sci., September 1, 2001; 945(1): 93 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bharadwaj, C. Mold, E. Markham, and T. W. Du Clos Serum Amyloid P Component Binds to Fc{{gamma}} Receptors and Opsonizes Particles for Phagocytosis J. Immunol., June 1, 2001; 166(11): 6735 - 6741. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mold, H. D. Gresham, and T. W. Du Clos Serum Amyloid P Component and C-Reactive Protein Mediate Phagocytosis Through Murine Fc{{gamma}}Rs J. Immunol., January 15, 2001; 166(2): 1200 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Sobel, C. Mohan, L. Morel, J. Schiffenbauer, and E. K. Wakeland Genetic Dissection of SLE Pathogenesis: Adoptive Transfer of Sle1 Mediates the Loss of Tolerance by Bone Marrow-Derived B Cells J. Immunol., February 15, 1999; 162(4): 2415 - 2421. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |